Hepatitis C News and Research

Latest Hepatitis C News and Research

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Fungal infection causes around half of AIDS-related deaths, of which there were 1,100,000 in 2015. A first of its kind analysis – ‘Modelling reduction in AIDS deaths’ by the University of Manchester’s Professor David W Denning and published today in Philosophical Transactions of the Royal Society B – suggests that the opportunity to save lives is being missed.

25 Oct 2016

TSRI scientists discover reason for lack of successful HCV vaccine design

Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute have discovered one reason why success has so far been elusive.

24 Oct 2016

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have been published in the journal "Science Immunology".

21 Oct 2016

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase.

20 Oct 2016

Wyss Institute wins 'Best of What's New' award for paper-based rapid Zika test

A rapid Zika test, developed by an international, multi-institutional team of researchers led by synthetic biologist James Collins, Ph.D., at Harvard University's Wyss Institute for Biologically Inspired Engineering, has today been named a 2016 "Best of What's New" awards winner by Popular Science magazine in the Health category.

20 Oct 2016

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.

14 Oct 2016

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis.

13 Oct 2016

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Liver cancer is more common among Asian Americans in part because they are at high risk of HBV infection.

12 Oct 2016

Research findings provide new avenues to target virus infection

Viral infection is one of the leading medical challenges of the 21st Century, ranging from the Hepatitis C Virus (HCV) epidemic affecting 3% of the global population, to recent outbreaks of West Nile, Zika, and Ebola viruses.

12 Oct 2016

Parents do not perceive need to vaccinate children against influenza, study finds

Despite the fact that influenza leads to more hospitalizations and deaths among children than any other vaccine-preventable disease, parents frequently decline vaccinating their children against influenza because they don't perceive the need, according to a new case-control study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

30 Sep 2016

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure.

26 Sep 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

Global study assesses countries on health-related Sustainable Development Goals

Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.

24 Sep 2016

New global health strategy aims to eliminate HCV as global public health threat by 2030

Chronic infection by the hepatitis C virus (HCV) proved fatal for over 700,000 people worldwide in 2013, mainly as a result of liver damage. Although information on the epidemiology of transmission and infection is sparse, recent estimates put the global prevalence of HCV infection at 130-150 million people.

21 Sep 2016

Mice study finds new antiviral that can control flu infection

A molecule the body produces naturally in response to virus infection could be a viable flu treatment in the future, suggest researchers at the Francis Crick Institute in London.

20 Sep 2016

Tips to prevent back-to-school illnesses in children

The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.

20 Sep 2016

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated liver injury, and some are currently in clinical trials.

9 Sep 2016

New vaccine against grass pollen allergies may help combat hepatitis B infection

A new type of vaccine against grass pollen allergies (BM32) might also offer an effective treatment for combating hepatitis B infection.

8 Sep 2016

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say.

7 Sep 2016

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

Hospitalizations for infective endocarditis, a heart valve infection often attributed to injection drug use, have increased significantly among young adult Americans--particularly in whites and females--according to a new study by researchers from Tufts Medical Center and Tufts University School of Medicine.

1 Sep 2016

Hepatitis C News and Research

Latest Hepatitis C News and Research

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

TSRI scientists discover reason for lack of successful HCV vaccine design

Scientists discover new mechanism for inadequate immune defense against chronic viral infection

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Wyss Institute wins 'Best of What's New' award for paper-based rapid Zika test

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Research findings provide new avenues to target virus infection

Parents do not perceive need to vaccinate children against influenza, study finds

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Global study assesses countries on health-related Sustainable Development Goals

New global health strategy aims to eliminate HCV as global public health threat by 2030

Mice study finds new antiviral that can control flu infection

Tips to prevent back-to-school illnesses in children

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

New vaccine against grass pollen allergies may help combat hepatitis B infection

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis C News and Research

Latest Hepatitis C News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in